143 related articles for article (PubMed ID: 12679153)
21. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.
Rudd JA; Tse JY; Wai MK
Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646
[TBL] [Abstract][Full Text] [Related]
22. Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonists.
Percie du Sert N; Rudd JA; Apfel CC; Andrews PL
Cancer Chemother Pharmacol; 2011 Mar; 67(3):667-86. PubMed ID: 20509026
[TBL] [Abstract][Full Text] [Related]
23. Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.
Goineau S; Guillaume P; Barrais L; Castagné V
Fundam Clin Pharmacol; 2014 Dec; 28(6):643-51. PubMed ID: 24750138
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced emesis in the Ferret: a new animal model.
Florczyk AP; Schurig JE; Bradner WT
Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
[TBL] [Abstract][Full Text] [Related]
25. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
Foss JF; Yuan CS; Roizen MF; Goldberg LI
Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin-induced early and delayed emesis in the pigeon.
Tanihata S; Igarashi H; Suzuki M; Uchiyama T
Br J Pharmacol; 2000 May; 130(1):132-8. PubMed ID: 10781008
[TBL] [Abstract][Full Text] [Related]
27. The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret.
Rudd JA; Naylor RJ
Eur J Pharmacol; 1997 Mar; 322(1):79-82. PubMed ID: 9088874
[TBL] [Abstract][Full Text] [Related]
28. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
[TBL] [Abstract][Full Text] [Related]
29. Action of Bacopa monnieri to antagonize cisplatin-induced emesis in Suncus murinus (house musk shrew).
Ullah I; Subhan F; Lu Z; Chan SW; Rudd JA
J Pharmacol Sci; 2017 Apr; 133(4):232-239. PubMed ID: 28363413
[TBL] [Abstract][Full Text] [Related]
30. Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets.
Tattersall FD; Rycroft W; Francis B; Pearce D; Merchant K; MacLeod AM; Ladduwahetty T; Keown L; Swain C; Baker R; Cascieri M; Ber E; Metzger J; MacIntyre DE; Hill RG; Hargreaves RJ
Neuropharmacology; 1996; 35(8):1121-9. PubMed ID: 9121615
[TBL] [Abstract][Full Text] [Related]
31. Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
Matsui K; Fukuoka M; Takada M; Kusunoki Y; Yana T; Tamura K; Yoshida T; Iida K; Hirashima T; Tsukada H; Ushijima S; Miyawaki H; Masuda N
Br J Cancer; 1996 Jan; 73(2):217-21. PubMed ID: 8546909
[TBL] [Abstract][Full Text] [Related]
32. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew).
Sam TS; Cheng JT; Johnston KD; Kan KK; Ngan MP; Rudd JA; Wai MK; Yeung JH
Eur J Pharmacol; 2003 Jul; 472(1-2):135-45. PubMed ID: 12860482
[TBL] [Abstract][Full Text] [Related]
33. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
Nakayama H; Yamakuni H; Nakayama A; Maeda Y; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2004 Nov; 96(3):301-6. PubMed ID: 15528840
[TBL] [Abstract][Full Text] [Related]
34. Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy.
Fukui H; Yamamoto M
Eur J Pharmacol; 1999 May; 372(3):261-7. PubMed ID: 10395021
[TBL] [Abstract][Full Text] [Related]
35. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
[TBL] [Abstract][Full Text] [Related]
36. 5-HT3 receptor antagonists in the control of cisplatin-induced delayed emesis.
Ossi M; Anderson E; Freeman A
Oncology; 1996 Jun; 53 Suppl 1():78-85. PubMed ID: 8692556
[TBL] [Abstract][Full Text] [Related]
37. The broad-spectrum anti-emetic activity of the novel non-peptide tachykinin NK1 receptor antagonist GR203040.
Gardner CJ; Twissell DJ; Dale TJ; Gale JD; Jordan CC; Kilpatrick GJ; Bountra C; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3158-63. PubMed ID: 8719790
[TBL] [Abstract][Full Text] [Related]
38. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
[TBL] [Abstract][Full Text] [Related]
39. Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret.
Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Lin G; Rudd JA
Toxicol Lett; 2010 Feb; 192(3):402-7. PubMed ID: 19931602
[TBL] [Abstract][Full Text] [Related]
40. Effects of Korean red ginseng extract on cisplatin-induced nausea and vomiting.
Kim JH; Yoon IS; Lee BH; Choi SH; Lee JH; Lee JH; Jeong SM; Kim SC; Park CK; Lee SM; Nah SY
Arch Pharm Res; 2005 Jun; 28(6):680-4. PubMed ID: 16042077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
